Status:
COMPLETED
Ictal and Interictal Inflammatory Markers in Migraine
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
University of Toledo Health Science Campus
The Cleveland Clinic
Conditions:
Migraine
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate blood levels of several proteins that may be altered in the inflammation associated with migraine headaches. These blood levels will be evaluated in individual...
Detailed Description
Migraine is a common, chronic disorder, which presents with recurrent episodes of disabling headache and affects approximately 12% of American adults.1,2 No biomarkers exist to identify episodic or ch...
Eligibility Criteria
Inclusion
- Age greater than 18 years of age, migraine
Exclusion
- Pregnant or breast-feeding women, presence of cardiovascular or cerebrovascular disorders as well as any known inflammatory, infectious, metabolic, thyroid, renal, cardiovascular or gastrointestinal diseases
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01138150
Start Date
September 1 2009
End Date
June 1 2013
Last Update
October 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Johns Hopkins Bayview Headache Center
Baltimore, Maryland, United States, 21224